6.
Gupta M, Abu Shehab M, Nygard K, Biggar K, Singal S, Santoro N
. IUGR Is Associated With Marked Hyperphosphorylation of Decidual and Maternal Plasma IGFBP-1. J Clin Endocrinol Metab. 2018; 104(2):408-422.
PMC: 6306389.
DOI: 10.1210/jc.2018-00820.
View
7.
Krishna R, Vishnu Bhat B
. Molecular mechanisms of intrauterine growth restriction. J Matern Fetal Neonatal Med. 2017; 31(19):2634-2640.
DOI: 10.1080/14767058.2017.1347922.
View
8.
Krishna R, Vishnu Bhat B, Bobby Z, Papa D, Badhe B, Chinnakali P
. Are Global DNA methylation and telomere length useful biomarkers for identifying intrauterine growth restricted neonates?. J Matern Fetal Neonatal Med. 2019; 34(5):761-764.
DOI: 10.1080/14767058.2019.1615875.
View
9.
Abu-Amero S, Ali Z, Bennett P, Vaughan J, Moore G
. Expression of the insulin-like growth factors and their receptors in term placentas: a comparison between normal and IUGR births. Mol Reprod Dev. 1998; 49(3):229-35.
DOI: 10.1002/(SICI)1098-2795(199803)49:3<229::AID-MRD2>3.0.CO;2-Q.
View
10.
Koutsaki M, Sifakis S, Zaravinos A, Koutroulakis D, Koukoura O, Spandidos D
. Decreased placental expression of hPGH, IGF-I and IGFBP-1 in pregnancies complicated by fetal growth restriction. Growth Horm IGF Res. 2011; 21(1):31-6.
DOI: 10.1016/j.ghir.2010.12.002.
View
11.
Giudice L, de Zegher F, Gargosky S, Dsupin B, Las Fuentes L, Crystal R
. Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth. J Clin Endocrinol Metab. 1995; 80(5):1548-55.
DOI: 10.1210/jcem.80.5.7538146.
View
12.
Leger J, Noel M, Limal J, Czernichow P
. Growth factors and intrauterine growth retardation. II. Serum growth hormone, insulin-like growth factor (IGF) I, and IGF-binding protein 3 levels in children with intrauterine growth retardation compared with normal control subjects: prospective.... Pediatr Res. 1996; 40(1):101-7.
DOI: 10.1203/00006450-199607000-00018.
View
13.
Randhawa R, Cohen P
. The role of the insulin-like growth factor system in prenatal growth. Mol Genet Metab. 2005; 86(1-2):84-90.
DOI: 10.1016/j.ymgme.2005.07.028.
View
14.
Gu T, Gu H, Hilding A, Sjoholm L, Ostenson C, Ekstrom T
. Increased DNA methylation levels of the insulin-like growth factor binding protein 1 gene are associated with type 2 diabetes in Swedish men. Clin Epigenetics. 2013; 5(1):21.
PMC: 3843565.
DOI: 10.1186/1868-7083-5-21.
View
15.
McLellan K, Hooper S, Bocking A, Delhanty P, Phillips I, Hill D
. Prolonged hypoxia induced by the reduction of maternal uterine blood flow alters insulin-like growth factor-binding protein-1 (IGFBP-1) and IGFBP-2 gene expression in the ovine fetus. Endocrinology. 1992; 131(4):1619-28.
DOI: 10.1210/endo.131.4.1382958.
View
16.
Tapanainen P, Bang P, Wilson K, Unterman T, Vreman H, Rosenfeld R
. Maternal hypoxia as a model for intrauterine growth retardation: effects on insulin-like growth factors and their binding proteins. Pediatr Res. 1994; 36(2):152-8.
DOI: 10.1203/00006450-199408000-00004.
View
17.
Popovici R, Lu M, Bhatia S, Faessen G, Giaccia A, Giudice L
. Hypoxia regulates insulin-like growth factor-binding protein 1 in human fetal hepatocytes in primary culture: suggestive molecular mechanisms for in utero fetal growth restriction caused by uteroplacental insufficiency. J Clin Endocrinol Metab. 2001; 86(6):2653-9.
DOI: 10.1210/jcem.86.6.7526.
View
18.
Verhaeghe J, Van Bree R, Van Herck E, Laureys J, Bouillon R, Van Assche F
. C-peptide, insulin-like growth factors I and II, and insulin-like growth factor binding protein-1 in umbilical cord serum: correlations with birth weight. Am J Obstet Gynecol. 1993; 169(1):89-97.
DOI: 10.1016/0002-9378(93)90137-8.
View
19.
Kajimura S, Aida K, Duan C
. Insulin-like growth factor-binding protein-1 (IGFBP-1) mediates hypoxia-induced embryonic growth and developmental retardation. Proc Natl Acad Sci U S A. 2005; 102(4):1240-5.
PMC: 545835.
DOI: 10.1073/pnas.0407443102.
View
20.
Crossey P, Pillai C, Miell J
. Altered placental development and intrauterine growth restriction in IGF binding protein-1 transgenic mice. J Clin Invest. 2002; 110(3):411-8.
PMC: 151083.
DOI: 10.1172/JCI10077.
View